Abstract
Rituximab for Preventing Delayed Hemolytic Transfusion Reaction (DHTR) in Sickle CELL Adult Patients: Outcome of Transfusion and SIDE Effects in 58 CASES
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have